Cargando…
Procalcitonin levels in COVID-19 patients
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a pandemic. This study analysed 95 SARS-CoV-2-infected patients, including 62 moderate COVID-19 patients, 21 severe COVID-19 patients and 12 critical COVID-19...
Autores principales: | Hu, Rui, Han, Chaofei, Pei, Shiyao, Yin, Mingzhu, Chen, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286278/ https://www.ncbi.nlm.nih.gov/pubmed/32534186 http://dx.doi.org/10.1016/j.ijantimicag.2020.106051 |
Ejemplares similares
-
Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19
por: Cohen, Avi J., et al.
Publicado: (2023) -
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit
por: Heesom, Lesley, et al.
Publicado: (2020) -
N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients
por: Piechota, Mariusz, et al.
Publicado: (2006) -
Procalcitonin: A Reliable Marker for the Diagnosis of Neonatal Sepsis
por: Adib, Minoo, et al.
Publicado: (2012) -
Procalcitonin levels in salmonella infection
por: Mishra, Vikas, et al.
Publicado: (2015)